« Return to News | Ethics/Regulatory

Total AAHRPP-Accredited Organizations Tops 200

Wednesday, March 31, 2010 06:54 AM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited six additional organizations, bringing the total number of AAHRPP-accredited organizations above 200. The latest accreditation recipients included three universities, two independent IRBs, and a teaching hospital system.

The organizations that received full accreditation are Columbia University of the City of New York, New York, NY; Sterling Institutional Review Board, Atlanta, Ga.; The Greenville Hospital System, Greenville, S.C.; The Ohio State University, Columbus, Ohio; and University of Illinois at Chicago, Chicago, Ill.

Harrison IRB in London, Ohio achieved qualified accreditation.

AAHRPP accredits organizations that conduct or review research with humans. Earlier this year, the organization made changes to its accreditation process, extending the time period between reaccreditations from three years to five. The organization also revised its reporting procedure to request more specific information about changes and catastrophic events, and made it possible for AAHRPP’s Council on Accreditation to request status reports and conduct limited site visits to organizations to verify standards-compliance efforts.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.